The clinical presentation of these patients resembles TEFM mutations with global developmental delay, hypotonia, short stature, intellectual disability, dysmorphic features and/or epileptic seizures in childhood, while other subjects developed muscle weakness and atrophy or autosomal dominant progressive external ophthalmoplegia. This evidence concerns the gene TEFM and autosomal dominant progressive external ophthalmoplegia.